Nanjing Hicin Pharmaceutical Co Ltd Financial Flexibility Index
Nanjing Hicin Pharmaceutical Co Ltd financial flexibility index. Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥10.70 Million (operating CF CN¥-7.15 Million minus capex CN¥17.85 Million) represents 0% of total liabilities (CN¥410.14 Million). Explore Nanjing Hicin Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Nanjing Hicin Pharmaceutical Co Ltd (2012–2025)
Financial flexibility index of Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2025. Historical Financial Flexibility Index trend for Nanjing Hicin Pharmaceutical Co Ltd across 14 annual periods. Check cash flow reinvestment rate of Nanjing Hicin Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Nanjing Hicin Pharmaceutical Co Ltd Financial Flexibility Index by Year (2012–2025)
Nanjing Hicin Pharmaceutical Co Ltd financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Nanjing Hicin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Nanjing Hicin Pharmaceutical Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.33x | CN¥140.73 Million | CN¥78.09 Million | CN¥432.26 Million | ▲ +0.7% |
| 2024 | 0.32x | CN¥137.90 Million | CN¥59.96 Million | CN¥426.37 Million | ▼ -38.4% |
| 2023 | 0.52x | CN¥221.15 Million | CN¥23.93 Million | CN¥421.37 Million | ▼ -15.4% |
| 2022 | 0.62x | CN¥213.12 Million | CN¥-5.82 Million | CN¥343.38 Million | ▲ +42.2% |
| 2021 | 0.44x | CN¥154.35 Million | CN¥59.94 Million | CN¥353.53 Million | ▼ -48.7% |
| 2020 | 0.85x | CN¥193.49 Million | CN¥73.39 Million | CN¥227.55 Million | ▲ +30.1% |
| 2019 | 0.65x | CN¥140.64 Million | CN¥97.28 Million | CN¥215.19 Million | ▼ -9.4% |
| 2018 | 0.72x | CN¥153.88 Million | CN¥77.21 Million | CN¥213.26 Million | ▼ -26.9% |
| 2017 | 0.99x | CN¥113.08 Million | CN¥46.56 Million | CN¥114.61 Million | ▲ +12.0% |
| 2016 | 0.88x | CN¥83.37 Million | CN¥37.74 Million | CN¥94.66 Million | ▼ -6.6% |
| 2015 | 0.94x | CN¥82.53 Million | CN¥53.90 Million | CN¥87.55 Million | ▲ +65.4% |
| 2014 | 0.57x | CN¥53.36 Million | CN¥24.29 Million | CN¥93.63 Million | ▼ -50.4% |
| 2013 | 1.15x | CN¥86.77 Million | CN¥45.16 Million | CN¥75.49 Million | ▼ -37.5% |
| 2012 | 1.84x | CN¥106.79 Million | CN¥38.77 Million | CN¥58.03 Million | — |